// App-Quantinova.ai

3400 : Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

Researchers

Presenter

  • Jeanne M. Palmer

Principal Investigators

  • Claire Harrison

  • Amylou C. Dueck

  • Ryan Eckert

  • Heidi E. Kosiorek

  • Pablo Muxi

  • Naveen Pemmaraju

  • Guillermo Ruiz Arguelles

  • Alessandro Vannucchi

  • Vikas Gupta

  • John Mascarenhas

  • Kerry Taylor

  • Krisstina L. Gowin

  • Holly L. Geyer

  • Kazuya Shimoda

  • Jean-Jacques Kiladjian

  • Norio Komatsu

  • Grace Kam Li Shan

  • Virginia Abello

  • David Gomez-Almaguer

  • Robyn M. Scherber

  • Qian Jiang

  • Xuelan Zuo

  • Jennifer Huberty

  • Lesley Anderson

  • Blake T. Langlais

  • Ann Brazeau

  • Michelle Woehrle

  • Michael J. Mauro

  • Ruben Mesa

Medical Centers

  • Mayo Clinic, Phoenix, AZ

  • Department of Health Sciences Research, Mayo Clinic, Rochester, MN

  • Department of Haematology, Guys and St Thomas Hospitals NHS Trust, London, United Kingdom

  • Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA

  • British Hospital, Montevideo, Uruguay

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Centro de Hematologia y Medicina Interna, Puebla, Mexico

  • CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

  • Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

  • Mount Sinai School of Medicine, New York, NY

  • Mater Hospital, Brisbane, Australia

  • Department of Hematology-Oncology, University of Arizona, Tucson, AZ

  • Mayo Clinic, Scottsdale, AZ

  • Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, Toyama, Japan

  • Université de Paris, Clinical Investigations Center, Saint-Louis hospital, APHP, Paris, France

  • Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

  • Singapore General Hospital, Singapore, Singapore

  • Hospital San Jose, Bogota, Colombia

  • Universidad Autonoma de Nuevo Leon "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

  • Incyte Corporation, Wilmington, DE

  • Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

  • Department of Hematology, Zhongda Hospital of Southeast University, Nanjing, China

  • School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ

  • Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom

  • MPN Advocacy and Education, Chicago, IL

  • MPN Research Foundation, Chicago, IL

  • Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York

  • UT Health San Antonio Cancer Center, San Antonio, TX

Locations

  • United States

  • United Kingdom

  • Uruguay

  • Mexico

  • Italy

  • Canada

  • Australia

  • Japan

  • Singapore

  • Colombia

  • China

Companies

  • Incyte Corporation

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved